This inventor holds 3 USPTO granted patents and 15 published patent applications and 8 EPO patents. Top assignee: Bostongene Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Alexander Bagaev: Innovator in Cancer Research
Introduction
Alexander Bagaev is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer research, particularly in understanding tumor microenvironments. His work focuses on the immune escape mechanisms and immune infiltration associated with various cancers.
Latest Patents
Bagaev holds a patent for a groundbreaking invention titled "Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration." This patent encompasses methods, systems, and computer-readable storage media that are instrumental in characterizing subjects with specific cancers, especially those characterized by solid tumors. The disclosure outlines methods for determining a tumor microenvironment (TME) type of a cancer subject, which aids in assessing the subject's prognosis and their likelihood of responding to various therapies based on the TME type determination. He has 1 patent to his name.
Career Highlights
Bagaev is currently associated with Bostongene Corporation, where he continues to advance his research in cancer diagnostics and treatment. His innovative approaches have the potential to transform how cancer is understood and treated, paving the way for more personalized medicine.
Collaborations
He collaborates with talented individuals in his field, including Sofya Kust and Anastasia Zotova. Their combined expertise contributes to the ongoing research and development efforts at Bostongene Corporation.
Conclusion
Alexander Bagaev is a prominent figure in cancer research, with a focus on tumor microenvironments and immune mechanisms. His contributions through patents and collaborations are vital in the quest for improved cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
